EVOKE PLC/ GI000A0F6407 /
| 2024-06-07 5:26:49 PM | Chg. -0.25 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 86.05GBX | -0.29% | 17,578 Turnover(GBP): 14,979.2438 |
-Bid Size: - | -Ask Size: - | 86.15 | 84.45 |
GlobeNewswire
06-08
4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion C...
GlobeNewswire
06-07
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
06-06
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
06-05
Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying ...
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire
05-29
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2...
GlobeNewswire
05-21
Numi Organic Tea Launches Relax and Regenerate Herbal Supplement Tea Line Featuring Damiana
GlobeNewswire
05-20
Vancouver Video Production by Cinematix Media Launches Video Production Services in Canada
GlobeNewswire
05-16
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care ...
GlobeNewswire
05-15
Blade and Emirates partner to enable seamless booking of flights between Dubai and Monaco
GlobeNewswire
05-14
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
GlobeNewswire
05-14
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-14
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-09
Altimmune Announces First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
05-07
Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and W...
